Novel sirolimus-coated balloon catheter

Circulation: Cardiovascular Interventions

Volumn 9, Issue 4, 2016, Pages

  Clever, Yvonne Patricia ^a   Peters, Daniel ^b   Calisse, Jorge ^c   Bettink, Stephanie ^a   Berg, Madeleine Caroline ^c   Sperling, Christian ^c   Stoever, Michael ^c   Cremers, Bodo ^a   Kelsch, Bettina ^b   Böhm, Michael ^a   Speck, Ulrich ^b   Scheller, Bruno ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c B Braun Melsungen AG   (Germany)

Author keywords

angioplasty; drug coated balloon; drug eluting stent; neointima; sirolimus

Indexed keywords

BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT; RAPAMYCIN;

ANIMAL; ANIMAL MODEL; CELL PROLIFERATION; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY BLOOD VESSEL; DEVICES; DIAGNOSTIC IMAGING; DRUG EFFECTS; DRUG ELUTING STENT; EQUIPMENT DESIGN; HEART CATHETER; MALE; METABOLISM; NEOINTIMA; PATHOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PIG; TIME FACTOR;

ANIMALS; CARDIAC CATHETERS; CARDIOVASCULAR AGENTS; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; MALE; MODELS, ANIMAL; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION; SIROLIMUS; SWINE; TIME FACTORS;

EID: 84964553508     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.115.003543     Document Type: Article

References (49)

1. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U, Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008 358 689 699. doi: 10.1056/NEJMoa0706356
2. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J, Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008 118 1358 1365. doi: 10.1161/CIRCULATIONAHA.107.735985
3. Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ, Snead DB, Alexander B, Landini M, Jaff MR, IN.PACT SFA Trial Investigators Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 2015 131 495 502. doi: 10.1161/CIRCULATIONAHA.114.011004
4. Cortese B, Granada JF, Scheller B, Schneider PA, Tepe G, Scheinert D, Garcia L, Stabile E, Alfonso F, Ansel G, Zeller T, Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document [published online ahead of print May 24, 2015]. Eur Heart J
5. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U, Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006 355 2113 2124. doi: 10.1056/NEJMoa061254
6. Scheller B, Clever YP, Kelsch B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Speck U, Böhm M, Cremers B, Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv 2012 5 323 330. doi: 10.1016/j.jcin.2012.01.008
7. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B, Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009 119 2986 2994. doi: 10.1161/CIRCULATIONAHA.108.839282
8. Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Breithardt OA, Schmidt M, Zimmermann S, Lonke S, von Cranach M, Nguyen TV, Daniel WG, Wöhrle J, A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 2012 59 1377 1382. doi: 10.1016/j.jacc.2012.01.015
9. Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y, Eguchi H, Miyake K, Yoshino M, Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv 2011 4 149 154. doi: 10.1016/j.jcin.2010.10.012
10. Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, Fusaro M, Ott I, Ibrahim T, Hausleiter J, Valina C, Pache J, Laugwitz KL, Massberg S, Kastrati A, ISAR-DESIRE 3 investigators Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 2013 381 461 467. doi: 10.1016/S0140-6736(12)61964-3
11. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, 2014 ESC/EACTS guidelines on myocardial revascularization: The task force on myocardial revascularization of the european society of cardiology (ESC) and the european association for cardio-thoracic surgery (EACTS): developed with the special contribution of the european association of percutaneous cardiovascular interventions (EAPCI). Eur Heart J 2014 35 2541 2619
12. Kleber FX, Rittger H, Bonaventura K, Zeymer U, Wöhrle J, Jeger R, Levenson B, Möbius-Winkler S, Bruch L, Fischer D, Hengstenberg C, Pörner T, Mathey D, Scheller B, Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol 2013 102 785 797. doi: 10.1007/s00392-013-0609-7
13. Zeymer U, Waliszewski M, Spiecker M, Gastmann O, Faurie B, Ferrari M, Alidoosti M, Palmieri C, Heang TN, Ong PJ, Dietz U, Prospective 'real world' registry for the use of the 'PCB only' strategy in small vessel de novo lesions. Heart 2014 100 311 316. doi: 10.1136/heartjnl-2013-304881
14. Fischer D, Scheller B, Schäfer A, Klein G, Böhm M, Clever Y, Cremers B, Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study. EuroIntervention 2012 8 450 455. doi: 10.4244/EIJV8I4A71
15. Clever YP, Cremers B, Speck U, Dietz U, Böhm M, Scheller B, Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent. Catheter Cardiovasc Interv 2014 84 323 331. doi: 10.1002/ccd.25184
16. Poerner TC, Otto S, Gassdorf J, Nitsche K, Janiak F, Scheller B, Goebel B, Jung C, Figulla HR, Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up. Circ Cardiovasc Interv 2014 7 760 767. doi: 10.1161/CIRCINTERVENTIONS.113.001146
17. Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Bräunlich S, Ick H, Schuster J, Botsios S, Kruse HJ, Varcoe RL, Scheinert D, First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol 2011 58 1105 1109. doi: 10.1016/j.jacc.2011.05.034
18. Liistro F, Porto I, Angioli P, Grotti S, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L, Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation 2013 128 615 621. doi: 10.1161/CIRCULATIONAHA.113.001811
19. Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A, Peeters P, Vermassen F, Landini M, Snead DB, Kent KC, Rocha-Singh KJ, IN.PACT DEEP Trial Investigators Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol 2014 64 1568 1576. doi: 10.1016/j.jacc.2014.06.1198
20. Speck U, Cremers B, Kelsch B, Biedermann M, Clever YP, Schaffner S, Mahnkopf D, Hanisch U, Böhm M, Scheller B, Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel? Circ Cardiovasc Interv 2012 5 392 400. doi: 10.1161/CIRCINTERVENTIONS.111.967794
21. Rowinsky EK, Donehower RC, Paclitaxel (taxol). N Engl J Med 1995 332 1004 1014. doi: 10.1056/NEJM199504133321507
22. Mori T, Kinoshita Y, Watanabe A, Yamaguchi T, Hosokawa K, Honjo H, Retention of paclitaxel in cancer cells for 1 week in vivo and in vitro. Cancer Chemother Pharmacol 2006 58 665 672. doi: 10.1007/s00280-006-0209-6
23. Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G, Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004 110 810 814. doi: 10.1161/01.CIR.0000138929.71660.E0
24. Granada JF, Tellez A, Baumbach WR, Bingham B, Keng YF, Wessler J, Conditt G, McGregor J, Stone G, Kaluza GL, Leon MB, In vivo delivery and long-term tissue retention of nano-encapsulated sirolimus using a novel porous balloon angioplasty system [published online ahead of print October 2, 2015]. EuroIntervention. doi: 10.4244/EIJY16M10-01
25. Cremers B, Toner JL, Schwartz LB, von Oepen R, Speck U, Kaufels N, Clever YP, Mahnkopf D, Böhm M, Scheller B, Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clin Res Cardiol 2012 101 469 476. doi: 10.1007/s00392-012-0415-7
26. Kolachalama VB, Pacetti SD, Franses JW, Stankus JJ, Zhao HQ, Shazly T, Nikanorov A, Schwartz LB, Tzafriri AR, Edelman ER, Mechanisms of tissue uptake and retention in zotarolimus-coated balloon therapy. Circulation 2013 127 2047 2055. doi: 10.1161/CIRCULATIONAHA.113.002051
27. Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R, Yeung AC, Llanos G, Dooley J, Falotico R, Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004 63 617 624. doi: 10.1016/j.cardiores.2004.04.029
28. Marx SO, Marks AR, Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 2001 104 852 855
29. Kelsch B, Scheller B, Biedermann M, Clever YP, Schaffner S, Mahnkopf D, Speck U, Cremers B, Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Invest Radiol 2011 46 255 263. doi: 10.1097/RLI.0b013e31820577df.
30. Cremers B, Schmitmeier S, Clever YP, Gershony G, Speck U, Scheller B, Inhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter. Catheter Cardiovasc Interv 2014 84 1089 1098. doi: 10.1002/ccd.25296
31. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR, Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992 19 267 274
32. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB, In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998 31 224 230
33. Smith MP, Newstead CG, Ahmad N, Lewington AJ, Tibble S, Lodge JP, Pollard SG, Baker RJ, Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantation. Transplantation 2008 85 636 639. doi: 10.1097/TP.0b013e3181613e65
34. Byrne RA, Kastrati A, Tiroch K, Schulz S, Pache J, Pinieck S, Massberg S, Seyfarth M, Laugwitz KL, Birkmeier KA, Schömig A, Mehilli J, ISAR-TEST-2 Investigators 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents. J Am Coll Cardiol 2010 55 2536 2543. doi: 10.1016/j.jacc.2010.03.020
35. Massberg S, Byrne RA, Kastrati A, Schulz S, Pache J, Hausleiter J, Ibrahim T, Fusaro M, Ott I, Schömig A, Laugwitz KL, Mehilli J, Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus- Eluting Stents (ISAR-TEST 5) Investigators Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial. Circulation 2011 124 624 632. doi: 10.1161/CIRCULATIONAHA.111.026732
36. Rogers C, Huynh R, Seifert PA, Chevalier B, Schofer J, Edelman ER, Toegel G, Kuchela A, Woupio A, Kuntz RE, Macon ND, Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation 2004 109 1735 1740. doi: 10.1161/01.CIR.0000124724.14491.6F.
37. Speck U, Scheller B, Abramjuk C, Breitwieser C, Dobberstein J, Boehm M, Hamm B, Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 2006 240 411 418. doi: 10.1148/radiol.2402051248
38. Cremers B, Milewski K, Clever YP, Aboodi MS, Biedermann M, Thim T, Kelsch B, Kaluza GL, Scheller B, Granada JF, Long-term effects on vascular healing of bare metal stents delivered via paclitaxel-coated balloons in the porcine model of restenosis. Catheter Cardiovasc Interv 2012 80 603 610. doi: 10.1002/ccd.24305
39. Windecker S, Stortecky S, Stefanini GG, da Costa BR, daCosta BR, Rutjes AW, Di Nisio M, Silletta MG, Siletta MG, Maione A, Alfonso F, Clemmensen PM, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter D, Schauerte P, Sousa Uva M, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, Kolh P, Jüni P, Juni P, Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-Analysis. BMJ 2014 348 g3859
40. Serruys PW, Sianos G, Abizaid A, Aoki J, den Heijer P, Bonnier H, Smits P, McClean D, Verheye S, Belardi J, Condado J, Pieper M, Gambone L, Bressers M, Symons J, Sousa E, Litvack F, The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES). J Am Coll Cardiol 2005 46 253 260. doi: 10.1016/j.jacc.2005.03.069
41. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Mudde C, Tielemans H, Bérégi JP, Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005 16 331 338. doi: 10.1097/01.RVI.0000151260.74519.CA.
42. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Snyder SA, O'Leary EE, Tepe G, Scheinert D, Zeller T, Zilver PTX Investigators Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-Arm clinical studies. J Am Coll Cardiol 2013 61 2417 2427. doi: 10.1016/j.jacc.2013.03.034
43. Scheller B, Speck U, Schmitt A, Clauss W, Sovak M, Böhm M, Stoll HP, Acute cardiac tolerance of current contrast media and the new taxane protaxel using iopromide as carrier during porcine coronary angiography and stenting. Invest Radiol 2002 37 29 34
44. Clever YP, Cremers B, Krauss B, Böhm M, Speck U, Laufs U, Scheller B, Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells. EuroIntervention 2011 7(suppl K) K32 K42. doi: 10.4244/EIJV7SKA6
45. Levin AD, Vukmirovic N, Hwang CW, Edelman ER, Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc Natl Acad Sci U S A 2004 101 9463 9467. doi: 10.1073/pnas.0400918101
46. Granada JF, Stenoien M, Buszman PP, Tellez A, Langanki D, Kaluza GL, Leon MB, Gray W, Jaff MR, Schwartz RS, Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing. Open Heart 2014 1 e000117. doi: 10.1136/openhrt-2014-000117
47. Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García Del Blanco B, Seidelberger B, Iñiguez A, Gómez-Recio M, Masotti M, Velázquez MT, Sanchís J, García-Touchard A, Zueco J, Bethencourt A, Melgares R, Cequier A, Dominguez A, Mainar V, López-Mínguez JR, Moreu J, Martí V, Moreno R, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C, RIBS V Study Investigators, under the auspices of the Working Group on Interventional Cardiology of the Spanish Society of Cardiology A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent). J Am Coll Cardiol 2014 63 1378 1386. doi: 10.1016/j.jacc.2013.12.006
48. Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W, First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). JACC Cardiovasc Interv 2013 6 1026 1034. doi: 10.1016/j.jcin.2013.05.013
49. Wöhrle J, Zadura M, Möbius-Winkler S, Leschke M, Opitz C, Ahmed W, Barragan P, Simon JP, Cassel G, Scheller B, SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J Am Coll Cardiol 2012 60 1733 1738. doi: 10.1016/j.jacc.2012.07.040